Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against the original strain of the virus and some variants during animal testing.
Clover said in a statement its vaccine candidate demonstrated a “neutralisation” against the South African, Brazilian and UK variants among mice.
The company is testing a COVID-19 vaccine candidate containing an adjuvant, typically designed to boost the efficacy…
- Local News17 hours ago
WATCH LIVE: Gladys Berejiklian COVID-19 update press conference today ahead of Sydney lockdown decision
- Entertainment20 hours ago
Britney Spears is about to address the court on her conservatorship battle. Here’s what fans expect she’ll say – ABC News
- Entertainment17 hours ago
Disney casts its live-action Snow White
- Technology22 hours ago
Overwatch: How To Unlock The Ashe Challenge Skin – Forbes